GOVX new logo.png
GeoVax to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium
June 10, 2021 11:00 ET | GeoVax, Inc.
Atlanta, GA, June 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing human immunotherapies and vaccines against infectious diseases...
GOVX new logo.png
GeoVax to Present at 2021 BIO Digital
June 07, 2021 09:00 ET | GeoVax, Inc.
GeoVax Chairman & CEO to Participate in Vaccine Panel Discussion ATLANTA, GA, June 07, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company...
GOVX new logo.png
GeoVax Reports 2021 First Quarter Financial Results and Provides Corporate Update
May 06, 2021 16:00 ET | GeoVax, Inc.
Additional Capital Raised to Support Acceleration ofCoronavirus and Immuno-Oncology Programs  ATLANTA, GA, May 06, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX), a...
GOVX new logo.png
GeoVax to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021
May 06, 2021 11:30 ET | GeoVax, Inc.
GeoVax Chairman & CEO David Dodd to Participate in Panel Discussion ATLANTA, GA, May 06, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX), a biotechnology...
GOVX new logo.png
GeoVax to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update
April 26, 2021 09:00 ET | GeoVax, Inc.
Conference call to be held Thursday, May 6, at 4:30 p.m. Eastern Time ATLANTA, GA, April 26, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX) (“GeoVax” or the...
GOVX new logo.png
GeoVax Receives Notice of Allowance for Hepatitis B Vaccine Patent
April 01, 2021 09:00 ET | GeoVax, Inc.
Therapeutic Vaccine Would Address Medical Need of Over 250 Million Worldwide Atlanta, GA, April 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX) (“GeoVax” or the...
GOVX new logo.png
GeoVax Reports 2020 Year-End Financial Results And Provides Corporate Update
March 23, 2021 16:30 ET | GeoVax, Inc.
COVID-19 Vaccine Designed as Single-Dose Against Multiple Strains Immuno-Oncology Programs Advancing ATLANTA, GA, March 23, 2021 (GLOBE NEWSWIRE) -- via...
GOVX new logo.png
GeoVax to Participate in Benzinga Biotech Small Cap Conference
March 17, 2021 09:00 ET | GeoVax, Inc.
GeoVax Chairman & CEO David Dodd to Present Corporate OverviewGeoVax CSO, Mark Newman, PhD, to Participate in Immuno-Oncology Panel Discussion ATLANTA, GA, March 17, 2021 (GLOBE NEWSWIRE) --...
GOVX new logo.png
GeoVax to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update
March 15, 2021 09:00 ET | GeoVax, Inc.
Conference call to be held Wednesday, March 24, at 8:00 a.m. Eastern Time ATLANTA, GA, March 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire  -- GeoVax Labs, Inc. (NasdaqCM: GOVX), a biotechnology...
GOVX new logo.png
GeoVax to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference
March 10, 2021 09:00 ET | GeoVax, Inc.
GeoVax Chairman & CEO David Dodd to Present Corporate Overview GeoVax CSO, Mark Newman, PhD, to Participate in Immuno-Oncology Panel Discussion ATLANTA, GA, March 10, 2021 (GLOBE NEWSWIRE) --...